Cover Image
Market Research Report

US Market for Cardiac Surgery and Heart Valve Devices 2018 - MedView

Published by iData Research Inc. Product code 590185
Published Content info 366 Pages
Delivery time: 1-2 business days
Price
Back to Top
US Market for Cardiac Surgery and Heart Valve Devices 2018 - MedView
Published: November 1, 2017 Content info: 366 Pages
Description

The U.S. market for cardiac surgery and heart valve devices includes tissue heart valves, mechanical heart valves, annuloplasty repair devices, transcatheter mitral valve repair (TMVR) devices, transcatheter heart valve replacement (THVR) devices, on-pump coronary artery bypass (ONCAB) devices, off-pump coronary artery bypass (OPCAB) devices, endoscopic vessel harvesting (EVH) devices, anastomosis assist devices (AADs), transmyocardial revascularization (TMR) devices, ventricular assist devices (VADs), intra-aortic balloon pumps, temporary artificial heart replacement devices, extracorporeal membrane oxygenation (ECMO), remote hemodynamic monitoring, patent foramen ovale (PFO), atrial septal defect (ASD) devices, ventricular septal defect (VSD) devices and left atrial appendage (LAA) devices. Several new and innovative devices within this market are expected to emerge over the forecast period, particularly in the heart valve and cardiac assist segments, and as a result, growth in the overall market is expected to accelerate.

Cardiac surgery involves the heart and the great vessels connected to the heart. It is often performed to treat ischemic heart disease, congenital heart disease, valvular heart disease as well as heart transplantation. The first cardiac surgeries were performed in the 19th century on the pericardium, the sac that surrounds the heart. The first surgery on the heart itself was performed in 1895 in Oslo, Norway. Surgeon Axel Cappelen ligated the bleeding coronary artery of a 24-year-old patient who had been stabbed under his left arm. The patient survived for over two days but later passed away due to infection from the procedure. Approximately one year afterwards, a successful operation was performed in Germany on another patient with a stabbing injury. There are many risks associated with performing cardiac surgery. Patients often suffer from neurological damage and strokes after procedures. Neurological damage is more common when an ONCAB procedure is performed; many patients suffer from post-perfusion syndrome, which is a combination of neurological conditions that can affect patients after surgery. These symptoms can be temporary or permanent.

Table of Contents
Product Code: iDATA_USCS18_MV

TABLE OF CONTENTS I

LIST OF FIGURES XI

LIST OF CHARTS XIX

EXECUTIVE SUMMARY 1

U.S. CARDIAC SURGERY AND HEART VALVE DEVICE MARKET OVERVIEW 1

COMPETITIVE ANALYSIS 4

MARKET TRENDS 7

MARKET DEVELOPMENTS 11

PROCEDURE NUMBERS 12

PROCEDURE CODES INVESTIGATED 16

MARKETS INCLUDED 17

KEY REPORT UPDATES 19

VERSION HISTORY 20

RESEARCH METHODOLOGY 21

    • Step 1: Project Initiation & Team Selection 21
    • Step 2: Prepare Data Systems and Perform Secondary Research 24
    • Step 3: Preparation for Interviews & Questionnaire Design 26
    • Step 4: Performing Primary Research 27
    • Step 5: Research Analysis: Establishing Baseline Estimates 29
    • Step 6: Market Forecasts and Analysis 30
    • Step 7: Identify Strategic Opportunities 32
    • Step 8: Final Review and Market Release 33
    • Step 9: Customer Feedback and Market Monitoring 34

DISEASE OVERVIEW 35

  • 2.1 BASIC ANATOMY 35
    • 2.1.11 Coronary Artery Disease 37
    • 2.1.12 Myocardial Infarction 37
    • 2.1.13 Angina Pectoris 38
    • 2.1.14 Heart Valve Disease 39
    • 2.1.15 Congestive Heart Failure 39

U.S. CARDIAC SURGERY AND HEART VALVE DEVICE MARKET OVERVIEW 41

  • 3.1 INTRODUCTION 41
  • 3.2 MARKET OVERVIEW 43
  • 3.3 TREND ANALYSIS BY SEGMENT 49
  • 3.4 DRIVERS AND LIMITERS 54
    • 3.4.1 Market Drivers 54
    • 3.4.2 Market Limiters 55
  • 3.5 COMPETITIVE MARKET SHARE ANALYSIS 57
  • 3.6 COMPANY PROFILES 63
    • 3.6.1 Edwards Life Sciences 63
    • 3.6.2 Medtronic 63
    • 3.6.3 St. Jude Medical 66
    • 3.6.4 MAQUET 67
    • 3.6.5 Abiomed 68
    • 3.6.6 HeartWare Inc 69
  • 3.7 COMPANY SWOT ANALYSIS 70
    • 3.7.1 Edwards Life Sciences 70
    • 3.7.2 Medtronic 71
    • 3.7.3 St. Jude Medical 72
    • 3.7.4 MAQUET 73
    • 3.7.5 Abiomed 74
    • 3.7.6 HeartWare Inc. 75

ABBREVIATIONS 76

APPENDIX: COMPANY PRESS RELEASES 79

LIST OF CHARTS

  • Chart 1 1: Cardiac Surgery and Heart Valve Devices Market by Segment, U.S., 2014 - 2024 3
  • Chart 1 2: Cardiac Surgery and Heart Valve Devices Market Overview, U.S., 2017 & 2024 3
  • Chart 4 1: Cardiac Surgery and Heart Valve Device Market by Segment, U.S., 2014 - 2024 47
  • Chart 4 2: Cardiac Surgery and Heart Valve Device Market Breakdown, U.S., 2017 48
  • Chart 4 3: Cardiac Surgery and Heart Valve Device Market Breakdown, U.S., 2024 48
  • Chart 4 4: Growth Rates by Segment, Cardiac Surgery and Heart Valve Device Market, U.S., 2014 - 2024 53
  • Chart 4 5: Leading Competitors, Cardiac Surgery and Heart Valve Device Market, U.S., 2017 62

LIST OF FIGURES

  • Figure 1 1: Cardiac Surgery and Heart Valve Devices Market Share Ranking by Segment, U.S., 2017 (1 of 4) 4
  • Figure 1 2: Cardiac Surgery and Heart Valve Devices Market Share Ranking by Segment, U.S., 2017 (2 of 4) 5
  • Figure 1 3: Cardiac Surgery and Heart Valve Devices Market Share Ranking by Segment, U.S., 2017 (3 of 4) 5
  • Figure 1 4: Cardiac Surgery and Heart Valve Devices Market Share Ranking by Segment, U.S., 2017 (4 of 4) 5
  • Figure 1 5: Companies Researched in this Report, U.S., 2017 6
  • Figure 1 6: Factors Impacting the Cardiac Surgery and Heart Valve Devices Market by Segment, U.S. (1 of 4) 7
  • Figure 1 7: Factors Impacting the Cardiac Surgery and Heart Valve Devices Market by Segment, U.S. (2 of 4) 8
  • Figure 1 8: Factors Impacting the Cardiac Surgery and Heart Valve Devices Market by Segment, U.S. (3 of 4) 9
  • Figure 1 9: Factors Impacting the Cardiac Surgery and Heart Valve Devices Market by Segment, U.S. (4 of 4) 10
  • Figure 1 10: Recent Events in the Cardiac Surgery and Heart Valve Devices Market, U.S., 2015 - 2017 11
  • Figure 1 11: Cardiac Surgery and Heart Valve Devices Procedures Covered, U.S., 2017 (1 of 4) 12
  • Figure 1 12: Cardiac Surgery and Heart Valve Devices Procedures Covered, U.S., 2017 (2 of 4) 13
  • Figure 1 13: Cardiac Surgery and Heart Valve Devices Procedures Covered, U.S., 2017 (3 of 4) 14
  • Figure 1 14: Cardiac Surgery and Heart Valve Devices Procedures Covered, U.S., 2017 (4 of 4) 15
  • Figure 1 15: Procedure Codes Investigated, U.S., 2017 16
  • Figure 1 16: Cardiac Surgery and Heart Valve Devices Markets Covered, U.S., 2017 (1 of 2) 17
  • Figure 1 17: Cardiac Surgery and Heart Valve Devices Markets Covered, U.S., 2017 (2 of 2) 18
  • Figure 1 18: Key Report Updates (1 of 2) 19
  • Figure 1 19: Key Report Updates (2 of 2) 20
  • Figure 1 20: Version History 20
  • Figure 4 1: Cardiac Surgery and Heart Valve Device Market by Segment, U.S., 2014 - 2024 (US$M) (1 of 3) 44
  • Figure 4 2: Cardiac Surgery and Heart Valve Device Market by Segment, U.S., 2014 - 2024 (US$M) (2 of 3) 45
  • Figure 4 3: Cardiac Surgery and Heart Valve Device Market by Segment, U.S., 2014 - 2024 (US$M) (3 of 3) 46
  • Figure 4 4: Cardiac Surgery and Heart Valve Device Market Growth by Segment, U.S., 2014 - 2024 (1 of 3) 50
  • Figure 4 5: Cardiac Surgery and Heart Valve Device Market Growth by Segment, U.S., 2014 - 2024 (2 of 3) 51
  • Figure 4 6: Cardiac Surgery and Heart Valve Device Market Growth by Segment, U.S., 2014 - 2024 (3 of 3) 52
  • Figure 4 7: Drivers and Limiters, Cardiac Surgery and Heart Valve Device Market, U.S., 2017 56
  • Figure 4 8: Leading Competitors, Cardiac Surgery and Heart Valve Device Market, U.S., 2017 (1 of 3) 59
  • Figure 4 9: Leading Competitors, Cardiac Surgery and Heart Valve Device Market, U.S., 2017 (2 of 3) 60
  • Figure 4 10: Leading Competitors, Cardiac Surgery and Heart Valve Device Market, U.S., 2017 (3 of 3) 61
  • Figure 4 11: SWOT Analysis, Edwards Life Sciences, 2017 70
  • Figure 4 12: SWOT Analysis, Medtronic, 2018 71
  • Figure 4 13: SWOT Analysis, St. Jude Medical, 2018 72
  • Figure 4 14: SWOT Analysis, MAQUET, 2018 73
  • Figure 4 15: SWOT Analysis, Abiomed, 2018 74
  • Figure 4 16: SWOT Analysis, HeartWare Inc, 2018 75
  • Figure 25 1: Press Release Summary 79
Back to Top